In September, a massive bill overhauling the FDA passed in the House and the Senate. In its September 21, 2007 article, Media Industry Helped Drug Firms Fight Ad Restraints, the Wall Street Journal reports that the proposed restrictions on drug advertisements did not pass in part due to the lobbying efforts of advertisers. In early drafts of the bill, the FDA was given the power to block a drug company from advertising a medication that caused serious safety concerns. In the version of the bill that passed, however, the FDA was not given the power to block ads but was rather given the power to require drug companies to submit TV ads for review before they run so that the FDA can recommend changes. The FDA was also empowered to levy fines for false and misleading advertising.
For more information, please see: